STAAR Surgical Co Deferred Income Tax Assets, Net
STAAR Surgical Co (STAA) had Deferred Income Tax Assets, Net of $1.09 million as of 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-12
- 2026-07-03: Deferred Income Tax Assets, Net $1.09M.
- 2026-04-03: Deferred Income Tax Assets, Net $1.09M.
- 2026-01-02: Deferred Income Tax Assets, Net $3.37M.
- 2025-09-26: Deferred Income Tax Assets, Net $1.98M.
| Period end | Deferred Income Tax Assets, Net | Deferred Income Tax Assets, Net as first filed |
|---|---|---|
| 2026-07-03 | $1.09M 10-Q · filed 2026-08-12 | |
| 2026-04-03 | $1.09M 10-Q · filed 2026-05-13 | |
| 2026-01-02 | $3.37M 10-Q · filed 2026-08-12 | |
| 2025-09-26 | $1.98M 10-Q · filed 2025-11-05 | |
| 2025-06-27 | $11.89M 10-Q · filed 2025-08-06 | |
| 2025-03-28 | $4.00M 10-Q · filed 2025-05-07 | |
| 2024-12-27 | $788.00K 10-K · filed 2026-03-03 | |
| 2024-09-27 | $5.32M 10-Q · filed 2024-10-30 | |
| 2024-06-28 | $5.08M 10-Q · filed 2024-08-07 | |
| 2024-03-29 | $5.13M 10-Q · filed 2024-05-07 | |
| 2023-12-29 | $5.19M 10-K · filed 2025-02-21 | |
| 2023-09-29 | $8.56M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $4.67M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $4.74M 10-Q · filed 2023-05-03 | |
| 2022-12-30 | $8.74M 10-K · filed 2024-02-27 | $4.82M 10-K · filed 2023-02-23 |
| 2022-09-30 | $3.71M 10-Q · filed 2022-11-02 | |
| 2022-07-01 | $3.22M 10-Q · filed 2022-08-10 | |
| 2022-04-01 | $3.33M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $3.81M 10-K · filed 2023-02-23 | |
| 2021-10-01 | $3.70M 10-Q · filed 2021-11-03 | |
| 2021-07-02 | $3.72M 10-Q · filed 2021-08-04 | |
| 2021-04-02 | $4.54M 10-Q · filed 2021-05-05 | |
| 2021-01-01 | $4.94M 10-K · filed 2022-02-23 | |
| 2020-10-02 | $5.01M 10-Q · filed 2020-11-04 | |
| 2020-07-03 | $5.11M 10-Q · filed 2020-08-05 | |
| 2020-01-03 | $4.41M 10-K · filed 2021-02-24 | $3.75M 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |